BLASTOID VARIANT MANTLE CELL LYMPHOMA
Clinical trials for BLASTOID VARIANT MANTLE CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BLASTOID VARIANT MANTLE CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for BLASTOID VARIANT MANTLE CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to control aggressive blood cancer in younger adults
Disease control OngoingThis study is testing a three-part treatment for younger patients newly diagnosed with mantle cell lymphoma, a type of blood cancer. First, patients receive two targeted drugs (ibrutinib and rituximab) to attack the cancer cells. Then, they receive a strong combination of chemoth…
Matched conditions: BLASTOID VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 22:56 UTC
-
New drug combo tested for Tough-to-Treat blood cancer
Disease control OngoingThis study is testing whether two oral medications, venetoclax and acalabrutinib, can help control mantle cell lymphoma that has returned or didn't respond to previous treatments. The trial involves 32 adults who have already tried at least one other therapy. Researchers want to …
Matched conditions: BLASTOID VARIANT MANTLE CELL LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC